N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat

Acta Physiologica Scandinavica

Volumn 158, Issue 3, 1996, Pages 269-273

  Grass, S ^a   Hoffmann, O ^a,b   Xu, X J ^a   Wiesenfeld Hallin, Z ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Sabbatsberg Hospital   (Sweden)

Author keywords

Analgesia; CGS19755; Dextromethorphan; Hot plate test; MK 801; NMDA receptor; Opiates

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; DEXTROMETHORPHAN; DIZOCILPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029844920     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1996.566309000.x     Document Type: Article

References (32)

1. Advokat, C. & Rhein, F.Q. 1995. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res 699, 157-160.
2. Arnér, S. & Meyerson, B.A. 1988. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33, 11-23.
3. Ben-Eliyahu, S., Marek, P., Vaccarino, A.L., Mogil, J.S., Sternberg, W.F. & Liebeskind, J.C. 1992. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 575, 304-308.
4. Benson, W.M., Stefko, P.L. & Randall, L.O. 1953. Comparative pharmacology of levorphanol, racemorphan and dextrorphan and related methyl ethers. J Pharmacol Exp Tber 109, 189-200.
5. Chapman, V. & Dickenson, A.H. 1992. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 573, 321-323.
6. Chapman, V., Honoré, P., Buritova, J. & Besson, J.M. 1995. Co-administration of morphine plus NMDA receptor antagonist profoundly reduces spinal c-Fos expression evoked prolonged inflammatory pain in the rat. INRC., st Andrews (Abstract).
7. Chen, L. & Huang, L.Y. 1991. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein-kinase C by a μ-opioids. Neuron 7, 319-326.
8. Dambisya, Y.M. & Lee, T.-L. 1994. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test. Methods Findings Exp Clin Pbarmacol 16, 179-184.
9. Davies, S.N. & Lodge, D. 1987. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res 424, 402-406.
10. Dickenson, A.H. & Sullivan, A.F. 1990. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res 506, 31-39.
11. Elliott, K., Hynansky, A. & Inturrisi, C.E. 1994a. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59, 361-368.
12. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56, 69-75.
13. Hao, J.-X. & Xu, X.-J. 1996. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists. Pain, (in press).
14. Hoffmann, O. & Wiesenfeld-Hallin, Z. 1996. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats. NeuroReport 7, 838-840.
15. 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. Life Sci 53, 1489-1494.
16. Kristensen, J.D., Karlsten, R., Gordh, T. & Berge, O.-G. 1994. The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat. Pain 56, 59-68.
17. Kristensen, J.D., Svensson, B.A. & Gordh, T. 1992. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51, 249-253.
18. Lehmann, J., Hutchison, A.J., McPherson, S.E., Mondadori, C., Schmutz, M., Sinton, C.M., Tsai, C., Murphy, D.E., Steel, D.J., Williams, M., Cheney, D.L. & Wood, P.L. 1988. CGS19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther 246, 65-75.
19. Lipton, S.A. 1993. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci 16, 527-533.
20. Lufty, K., Hurlbut, D.E. & Weber, E. 1993. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res 616, 83-88.
21. Lufty, K., Shen, K.Z., Kwon, I.-S., Cai, S.X., Woodward, R.M., Keano, J.F.W. & Weber, E. 1995. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur J Pharmacol 273, 187-189.
22. Mao, J., Price, D.D. & Mayer, D.J. 1995. Experimental mononeuropathy reduces the antinociceptive effect of morphine: implication for common intracellular mechanisms involved in morphine tolerance and hyperalgesia. Pain 61, 353-364.
23. Marek, P., Ben-Eliyahu, S., Gold, M.S. & Liebeskind, J.C. 1991. Excitatory amino acid antagonists (kynurenic acid and MK-802) attenuate the development of morphine tolerance in the rat. Brain Res 547, 77-81.
24. Näsström, J., Karlsson, U. & Post, C. 1992. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol 212, 21-29.
25. Rusin, K.I. & Randic, M. 1991. Modulation of NMDA-induced currents by mu-opioid receptor agonist DAGO in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett 124, 208-212.
26. Tortella, F.C., Pellicano, M. & Bowery, N.G. 1989. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci 10, 501-507.
27. Trujillo, K.A. & Akil, H. 1991. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87.
28. Wong, E.H.F., Kemp, J.A., Priest, T., Knight, A.P., Woodruff, G.N. & Iversen, L.L. 1986. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83, 7104-7108.
29. Woolf, C.J. & Thompson, S.W.N. 1991. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 44, 293-300.
30. Yamamoto, T. & Yaksh, T.L. 1992. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett 135, 67-70.
31. Ziegelgänsberger, W. & Tölle, T.R. 1993. The pharmacology of pain signalling. Curr Opinion Neurobiol 3, 611-618.
32. Ziegelgänsberger, W. & Tulloch, I.F. 1979. The effects of methionine- and leucine-enkephalin on spinal neurones of the cat. Brain Res 167, 53-64.